News
CDT
0.7131
-34.58%
-0.3769
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 20h ago
Major Insider Move Shakes Up CDT Equity Ownership
TipRanks · 2d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 3d ago
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 3d ago
Why Is CDT Equity Stock Surging On Monday?
Benzinga · 3d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 4d ago
Weekly Report: what happened at CDT last week (0615-0619)?
Weekly Report · 4d ago
Why Sagtec Global Shares Are Trading Higher By Around 76%; Here Are 20 Stocks Moving Premarket
Benzinga · 4d ago
CDT Equity Stock Gets A Boost On SarborgQ Development News
Benzinga · 06/18 17:21
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 06/18 17:06
Nasdaq Surges 300 Points; US Initial Jobless Claims Edge Lower
Benzinga · 06/18 14:53
NASDAQ TRADE HALT <CDT.O> VOLATILITY TRADING PAUSE AT 09:34 AM
Reuters · 06/18 13:34
CDT Equity notes investment into Sarborg, expansion into quantum computing
TipRanks · 06/18 13:07
CDT Equity Sarborg stake valued at $127.5 million after $125,000-a-share subscription
PUBT · 06/18 12:47
CDT Equity Highlights $127.5M Implied Value Of Sarborg Stake After New Funding Round Values AI And Quantum Computing Firm At $638.3M
Benzinga · 06/18 12:34
CDT Equity Simplifies Capital Structure With Single Lender Facility
TipRanks · 06/16 22:29
CDT Equity announces debt restructuring, new loan facility of up to $1.46M
Seeking Alpha · 06/16 13:10
CDT Equity repays $5.74 million A.G.P. convertible loan note
PUBT · 06/16 12:31
CDT EQUITY - WILL ELIMINATE OVER $6.3 MLN OF LEGACY FINANCING OBLIGATIONS
Reuters · 06/16 12:30
Weekly Report: what happened at CDT last week (0608-0612)?
Weekly Report · 06/15 10:14
More
Webull provides a variety of real-time CDT stock news. You can receive the latest news about CDT Equity through multiple platforms. This information may help you make smarter investment decisions.
About CDT
CDT Equity Inc., formerly Conduit Pharmaceuticals, Inc. is a data-driven biotech development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. Through advanced co-crystallization and solidform technologies developed at its Cambridge facility, it is engaged in improving drug properties and has helped in extending the patent life of certain drugs by up to 20 years. Its pipeline includes candidates targeting inflammatory and autoimmune disorders, as well as idiopathic male infertility, dermatology and animal health. It applies proprietary algorithms utilizing AI-powered disease mapping to identify novel repurposing opportunities against a database of over 800 disease signatures. In addition, the Company has initiated pre-clinical in-vitro models to explore new indications, guided by AI-insights without human intervention.